Highlights

03-12 JCDecaux, Maurel & Prom, Voltalia... stocks to watch today in Paris Zonebourse
03-09 Hutchmed announces update on licensed oncology product Tazverik in China RE
03-09 European Markets Plunge as Oil Surges Amid Geopolitical Pressure Zonebourse
03-09 HUTCHMED Limited Announces Update on Licensed Oncology Product Tazverik in China CI
03-09 Ipsen withdraws Tazverik® (tazemetostat) in follicular lymphoma, epithelioid sarcoma RE
03-09 Ipsen Voluntarily Withdraws Tazverik in Follicular Lymphoma and Epithelioid Sarcoma CI
02-27 Ipsen's Pediatric Low-Grade Glioma Therapy Recommended for EU Approval MT
02-12 Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook Alphavalue
02-12 Ipsen S.A. Provides Earnings Guidance for the Full Year 2026 CI
02-12 Ipsen Surges After Strong 2025 Results and Ambitious Targets Zonebourse
02-12 New Historic Record for the CAC 40 at Opening, Fresh Wave of Earnings Results Zonebourse
02-12 Carrefour, EssilorLuxottica, Hermès, Michelin, Rexel... Key Stocks to Watch Today in Paris Zonebourse
02-12 European Markets Expected to Rise, Corporate Earnings to Set the Pace for the Session Zonebourse
02-12 To Watch Today Zonebourse
02-12 Ipsen Increases Annual Net Profit by 28% Zonebourse
02-12 Ipsen FY revenue EUR 3,675.9 million RE
02-12 Ipsen S.A. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-09 Zonebourse Corporate Earnings Calendar: Week of February 9 to 13, 2026 Zonebourse
02-04 Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026 CI
01-27 Derichebourg, Hoffmann Green, OPmobility... Stocks to Watch Today in Paris - Zonebourse
01-22 Ipsen Surges After Favorable Court Ruling Zonebourse
01-22 Interparfums, Michelin, Société Générale, Ubisoft... Stocks to Watch Today in Paris Zonebourse
01-22 Clear Skies Ahead in Europe: Tariff Suspension Follows Trump-NATO Greenland Deal Zonebourse
01-22 Ipsen: To Watch Today Zonebourse
01-22 Ipsen Gets International Chamber of Commerce's Arbitral Tribunal's Final Ruling in Galderma Dispute MT
No results for this search
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW